Zkusit zdarma
Precision Drilling Corporation

Precision Drilling Corporation

PDS
Cena:
$ 96.99
+0.69 (0.72%)
Valuace
100
Růst
70
Zdraví
69
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
PDS Biotechnology Q1 Earnings Call Highlights

PDS Biotechnology Q1 Earnings Call Highlights

14:11 13-05-2026

PDS Biotechnology NASDAQ: PDSB reported a smaller first-quarter loss and highlighted changes to its ...

PDS Biotech Reports First Quarter 2026 Financial Results and Provides Clinical Programs and Corporate Update

PDS Biotech Reports First Quarter 2026 Financial Results and Provides Clinical Programs and Corporate Update

7:00 13-05-2026

Investor Webcast Scheduled for 8:00 am ET PRINCETON, N.J., May 13, 2026 (GLOBE NEWSWIRE) -- PDS Biot...

PDS Biotech Announces Conference Call and Webcast for 2026 First Quarter Financial Results

PDS Biotech Announces Conference Call and Webcast for 2026 First Quarter Financial Results

8:00 06-05-2026

PRINCETON, N.J., May 06, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“P...

Precision Drilling (PDS) Reports Next Week: Wall Street Expects Earnings Growth

Precision Drilling (PDS) Reports Next Week: Wall Street Expects Earnings Growth

11:02 22-04-2026

Precision Drilling (PDS) doesn't possess the right combination of the two key ingredients for a like...

Precision Drilling (NYSE:PDS) Shares Down 7.1% – Should You Sell?

Precision Drilling (NYSE:PDS) Shares Down 7.1% – Should You Sell?

3:58 19-04-2026

Shares of Precision Drilling Corporation (NYSE: PDS - Get Free Report) (TSE: PD) fell 7.1% during tr...

PDS Biotech Announces Publication of Positive PDS01ADC Interim Phase 2 Clinical Trial Data from Stage 1 of NCI-led Metastatic Colorectal Cancer (mCRC) Trial

PDS Biotech Announces Publication of Positive PDS01ADC Interim Phase 2 Clinical Trial Data from Stage 1 of NCI-led Metastatic Colorectal Cancer (mCRC) Trial

8:45 15-04-2026

78% Objective Response Rate (ORR) with PDS01ADC; Parallel trial without PDS01ADC had 35% ORR 2-year ...

Precision Drilling Corp (PDS) Shares Fall 3.2% -- What GF Score of 74 Tells Investors

Precision Drilling Corp (PDS) Shares Fall 3.2% -- What GF Score of 74 Tells Investors

19:21 14-04-2026

On April 14, 2026, Precision Drilling Corp (PDS) shares fell 3.2% to a current price of $89.96. This...

JPMorgan Chase & Co. Has $2.12 Million Position in Precision Drilling Corporation $PDS

JPMorgan Chase & Co. Has $2.12 Million Position in Precision Drilling Corporation $PDS

5:03 07-04-2026

JPMorgan Chase and Co. grew its holdings in shares of Precision Drilling Corporation (NYSE: PDS) (TS...

Precision Drilling Corporation Announces Filing of Management Information Circular and Virtual-Only Annual Meeting of Shareholders

Precision Drilling Corporation Announces Filing of Management Information Circular and Virtual-Only Annual Meeting of Shareholders

16:30 01-04-2026

CALGARY, Alberta, April 01, 2026 (GLOBE NEWSWIRE) -- Precision Drilling Corporation (Precision or th...

Precision Drilling Corporation (NYSE:PDS) Receives Average Rating of “Moderate Buy” from Analysts

Precision Drilling Corporation (NYSE:PDS) Receives Average Rating of “Moderate Buy” from Analysts

4:42 01-04-2026

Precision Drilling Corporation (NYSE: PDS - Get Free Report) (TSE: PD) has earned an average rating ...

Precision Drilling Corporation 2026 First Quarter Results Conference Call and Webcast

Precision Drilling Corporation 2026 First Quarter Results Conference Call and Webcast

18:15 31-03-2026

CALGARY, Alberta, March 31, 2026 (GLOBE NEWSWIRE) -- Precision Drilling Corporation (Precision) inte...

PDS Biotech Reports Full Year 2025 Financial Results and Provides Update on PDS0101 Phase 3 Program and PDS01ADC Clinical Advancement

PDS Biotech Reports Full Year 2025 Financial Results and Provides Update on PDS0101 Phase 3 Program and PDS01ADC Clinical Advancement

7:00 30-03-2026

Filed Phase 3 Amendment Incorporates PFS as Interim Primary Endpoint Expected to Shorten Trial Durat...

PDS Biotech Announces Conference Call and Webcast for 2025 Fourth Quarter and Year End Financial Results

PDS Biotech Announces Conference Call and Webcast for 2025 Fourth Quarter and Year End Financial Results

16:05 24-03-2026

PRINCETON, N.J., March 24, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (...

Precision Drilling Corporation Announces Filing of Annual Disclosure Documents

Precision Drilling Corporation Announces Filing of Annual Disclosure Documents

17:13 09-03-2026

CALGARY, Alberta, March 09, 2026 (GLOBE NEWSWIRE) -- Precision Drilling Corporation (Precision) anno...

PDS Health Enhances Marketing Performance with Marchex Conversation Intelligence

PDS Health Enhances Marketing Performance with Marchex Conversation Intelligence

8:30 09-03-2026

SEATTLE--(BUSINESS WIRE)--Marchex® (NASDAQ: MCHX), which harnesses the power of AI and conversation...

Precision Drilling: Soon Debt-Free And Increasing Shareholder Returns

Precision Drilling: Soon Debt-Free And Increasing Shareholder Returns

10:52 17-02-2026

Oilfield services have been in a bull market since Liberation Day; while things may start to look "f...

What Makes Precision Drilling (PDS) a Strong Momentum Stock: Buy Now?

What Makes Precision Drilling (PDS) a Strong Momentum Stock: Buy Now?

13:01 16-02-2026

Does Precision Drilling (PDS) have what it takes to be a top stock pick for momentum investors? Let'...

Precision Drilling Corporation (NYSE:PDS) Receives $99.00 Average Target Price from Analysts

Precision Drilling Corporation (NYSE:PDS) Receives $99.00 Average Target Price from Analysts

2:08 13-02-2026

Precision Drilling Corporation (NYSE: PDS - Get Free Report) (TSE: PD) has earned a consensus recomm...

Precision Drilling Q4 Earnings Call Highlights

Precision Drilling Q4 Earnings Call Highlights

2:08 13-02-2026

Precision Drilling (NYSE: PDS) executives highlighted debt reduction, share repurchases and steady o...

Precision Drilling (PDS) Q4 Earnings Beat Estimates

Precision Drilling (PDS) Q4 Earnings Beat Estimates

21:15 11-02-2026

Precision Drilling (PDS) came out with quarterly earnings of $1.37 per share, beating the Zacks Cons...

close

PRECISION DRILLING ANNOUNCES 2025 FOURTH QUARTER AND YEAR END UNAUDITED FINANCIAL RESULTS

11-02-2026
CALGARY, ALBERTA, FEB. 11, 2026 (GLOBE NEWSWIRE) -- THIS NEWS RELEASE CONTAINS “FORWARD-LOOKING IN...
Více zde

PDS BIOTECH ANNOUNCES PRESENTATION OF PRELIMINARY RESULTS FROM PHASE 2 STUDY OF IL-12 TUMOR TARGETED IMMUNOCYTOKINE (PDS01ADC) IN 3RD LINE METASTATIC CASTRATION RESISTANT PROSTATE CANCER BY THE NCI

28-01-2026
NCI-LED STUDY SHOWS MEDIAN PFS OF 9.6 MONTHS  RESULTS PRESENTED AT AACR SPECIAL CONFERENCE ON INNOV...
Více zde

PDS BIOTECH ANNOUNCES NEW U.S. PATENT COVERING TECHNOLOGY UNDERLYING PDS0101

22-01-2026
PATENT ENHANCES IP ESTATE FOR LEAD ASSET; COMBINED WITH ANTICIPATED BIOLOGICS EXCLUSIVITY, MARKET PR...
Více zde

PRECISION DRILLING CORPORATION 2025 FOURTH QUARTER AND YEAR-END RESULTS CONFERENCE CALL AND WEBCAST

05-01-2026
CALGARY, ALBERTA, JAN. 05, 2026 (GLOBE NEWSWIRE) -- PRECISION DRILLING CORPORATION (PRECISION) INTEN...
Více zde

PDS BIOTECH ANNOUNCES NEW COMPOSITION OF MATTER PATENT FOR PDS0101 IN JAPAN

09-12-2025
NEW PATENT GRANTS BROAD COMPOSITION CLAIMS FOR PDS0101 PREVIOUSLY GRANTED PATENT PROTECTIONS AND ANT...
Více zde

PDS BIOTECH ANNOUNCES SCHEDULING OF TYPE C MEETING WITH U.S. FOOD AND DRUG ADMINISTRATION (“FDA”)

02-12-2025
COMPANY TO DISCUSS PROPOSED AMENDMENT TO PHASE 3 VERSATILE-003 TRIAL ENABLING POTENTIAL ACCELERATED ...
Více zde

PDS BIOTECH REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND PROVIDES CLINICAL PROGRAMS UPDATE

13-11-2025
COMPANY ANNOUNCED COMPLETION OF VERSATILE-002 PHASE 2 TRIAL OF PDS0101 + PEMBROLIZUMAB IN HPV16-POSI...
Více zde

PDS BIOTECHNOLOGY ANNOUNCES UP TO $11.1 MILLION REGISTERED DIRECT OFFERING

11-11-2025
PRINCETON, N.J., NOV. 11, 2025 (GLOBE NEWSWIRE) -- PDS BIOTECHNOLOGY CORPORATION (NASDAQ: PDSB) (“...
Více zde

PDS BIOTECHNOLOGY ANNOUNCES TRANSLATIONAL DATA SHOWING STRONG IMMUNOLOGICAL AND CLINICAL ACTIVITY OF PDS0101 AND PDS01ADC PRESENTED AT SITC 2025

10-11-2025
TRANSLATIONAL STUDY SHOWS THAT MULTIPLE IMMUNOLOGICAL BIOMARKERS PREDICT THE CLINICAL ACTIVITY OF PD...
Více zde

PDS BIOTECH ANNOUNCES CONFERENCE CALL AND WEBCAST FOR THIRD QUARTER 2025 FINANCIAL RESULTS

06-11-2025
PRINCETON, N.J., NOV. 06, 2025 (GLOBE NEWSWIRE) -- PDS BIOTECHNOLOGY CORPORATION (NASDAQ: PDSB) (“...
Více zde

PDS BIOTECH TO SEEK EXPEDITED APPROVAL PATHWAY FOR PDS0101 IN HPV16-POSITIVE HEAD AND NECK CANCER

29-10-2025
COMPANY AIMS TO SHORTEN TIME FRAME TO MAKE PDS0101 AVAILABLE TO PATIENTS WITH HPV16-POSITIVE HEAD AN...
Více zde

PRECISION DRILLING ANNOUNCES 2025 THIRD QUARTER UNAUDITED FINANCIAL STATEMENTS

22-10-2025
CALGARY, ALBERTA, OCT. 22, 2025 (GLOBE NEWSWIRE) -- THIS NEWS RELEASE CONTAINS “FORWARD-LOOKING IN...
Více zde

PRECISION DRILLING CORPORATION 2025 THIRD QUARTER RESULTS CONFERENCE CALL AND WEBCAST

24-09-2025
CALGARY, ALBERTA, SEPT. 24, 2025 (GLOBE NEWSWIRE) -- PRECISION DRILLING CORPORATION (PRECISION) INTE...
Více zde

PDS BIOTECH SETS SIGNIFICANT BENCHMARK IN HEAD AND NECK CANCER BY ACHIEVING EXTENDED SURVIVAL IN LOW PD-L1 EXPRESSION (CPS 1–19) COHORT IN VERSATILE-002 TRIAL, POTENTIALLY ELIMINATING NEED FOR CHEMOTHERAPY IN THE POPULATION

18-09-2025
FIRST COMBINATION THERAPY TO REPORT 29.5 MONTHS OF MEDIAN OVERALL SURVIVAL (MOS); STANDARD OF CARE K...
Více zde

PDS BIOTECH TO PARTICIPATE IN THE H.C. WAINWRIGHT 27TH ANNUAL GLOBAL INVESTMENT CONFERENCE

02-09-2025
PRINCETON, N.J., SEPT. 02, 2025 (GLOBE NEWSWIRE) -- PDS BIOTECHNOLOGY CORPORATION (NASDAQ: PDSB) (...
Více zde

PDS BIOTECH ANNOUNCES FINAL TOPLINE SURVIVAL DATA FROM VERSATILE-002 PHASE 2 TRIAL IN HEAD AND NECK CANCER

25-08-2025
MEDIAN OVERALL SURVIVAL (MOS) OF 39.3 MONTHS IN PATIENTS WITH CPS ≥ 1 – BEST PUBLISHED RESULT WI...
Více zde

PDS BIOTECH REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND PROVIDES CLINICAL PROGRAMS UPDATE

13-08-2025
MULTIPLE ABSTRACTS PRESENTED AT THE 2025 AMERICAN SOCIETY OF CLINICAL ONCOLOGY ANNUAL MEETING CONFER...
Více zde

PDS BIOTECH ANNOUNCES CONFERENCE CALL AND WEBCAST FOR SECOND QUARTER 2025 FINANCIAL RESULTS

06-08-2025
PRINCETON, N.J., AUG. 06, 2025 (GLOBE NEWSWIRE) -- PDS BIOTECHNOLOGY CORPORATION (NASDAQ: PDSB) (“...
Více zde

PRECISION DRILLING ANNOUNCES 2025 SECOND QUARTER UNAUDITED FINANCIAL STATEMENTS

29-07-2025
CALGARY, ALBERTA, JULY 29, 2025 (GLOBE NEWSWIRE) -- THIS NEWS RELEASE CONTAINS “FORWARD-LOOKING IN...
Více zde

PDS BIOTECH ANNOUNCES COLORECTAL CANCER COHORT OF PHASE 2 CLINICAL TRIAL WITH PDS01ADC MET CRITERIA FOR EXPANSION TO STAGE 2 FOLLOWING POSITIVE STAGE 1 RESULTS

10-07-2025
PRINCETON, N.J., JULY 10, 2025 (GLOBE NEWSWIRE) -- PDS BIOTECHNOLOGY CORPORATION (NASDAQ: PDSB) (“...
Více zde

DEEP HOLE DRILLING MACHINE INDUSTRY REPORT 2025-2034 | INDUSTRY 4.0 INTEGRATION TRANSFORMING PRECISION DRILLING OPERATIONS, HYBRID MACHINES REVOLUTIONIZING HIGH-PRECISION MANUFACTURING SECTORS

04-07-2025
EXPLORE THE BOOMING GLOBAL DEEP HOLE DRILLING MACHINE MARKET, POISED TO SURGE FROM USD 1.13 BILLION ...
Více zde

PRECISION DRILLING CORPORATION 2025 SECOND QUARTER RESULTS CONFERENCE CALL AND WEBCAST

02-07-2025
CALGARY, ALBERTA, JULY 02, 2025 (GLOBE NEWSWIRE) -- PRECISION DRILLING CORPORATION (PRECISION) INTEN...
Více zde

PDS BIOTECH TO HOST KEY OPINION LEADER EVENT TO DISCUSS VERSAMUNE® HPV FOR THE TREATMENT OF HPV16+ HNSCC

09-06-2025
EVENT TO DISCUSS THE CHANGING LANDSCAPE OF HNSCC IN CONTEXT WITH THE MERCK KN-689 STUDY AND THE RAPI...
Více zde

PDS BIOTECH UNVEILS UPDATED POSITIVE DATA FROM VERSATILE-002 TRIAL AND ADDITIONAL TRIALS EVALUATING VERSAMUNE® HPV TO TREAT HEAD AND NECK CANCERS AT THE 2025 AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) ANNUAL MEETING

02-06-2025
PDS BIOTECH ANNOUNCED THE PUBLICATION OF THREE VERSAMUNE® HPV ABSTRACTS THAT WERE PRESENTED DURING ...
Více zde

PDS BIOTECH ANNOUNCES POSITIVE EXTENDED FOLLOW-UP DATA FOR VERSATILE-002 AND ADDITIONAL TRIALS EVALUATING VERSAMUNE® HPV TO BE PRESENTED AT THE 2025 AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) ANNUAL MEETING

22-05-2025
PHASE 2: VERSAMUNE ® HPV WITH PEMBROLIZUMAB AS 1L TREATMENT OF R/M HPV16-POSITIVE HNSCC...
Více zde

PDS BIOTECH TO PARTICIPATE AT THE A.G.P. VIRTUAL ANNUAL HEALTHCARE COMPANY SHOWCASE

20-05-2025
PRINCETON, N.J., MAY 20, 2025 (GLOBE NEWSWIRE) -- PDS BIOTECHNOLOGY CORPORATION (NASDAQ: PDSB) (“P...
Více zde

PRECISION DRILLING CORPORATION ANNOUNCES VOTING RESULTS FROM THE 2025 ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS

15-05-2025
CALGARY, ALBERTA, MAY 15, 2025 (GLOBE NEWSWIRE) -- PRECISION DRILLING CORPORATION (PRECISION OR THE ...
Více zde

PDS BIOTECH REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND PROVIDES CLINICAL PROGRAMS AND CORPORATE UPDATE

14-05-2025
VERSATILE-003 PHASE 3 SITE INITIATIONS UNDERWAY MULTIPLE ABSTRACTS SELECTED FOR PRESENTATION AT THE ...
Více zde

PDS HEALTH EXPANDS CYBERARK DEPLOYMENT TO AUTOMATE CERTIFICATE LIFECYCLE MANAGEMENT AT SCALE

13-05-2025
NEWTON, MASS. & PETACH TIKVA, ISRAEL--(BUSINESS WIRE)--CYBERARK (NASDAQ: CYBR), THE GLOBAL LEADER IN...
Více zde

PDS BIOTECHNOLOGY REPORTS INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)

09-05-2025
PRINCETON, N.J., MAY 09, 2025 (GLOBE NEWSWIRE) -- PDS BIOTECHNOLOGY CORPORATION (NASDAQ: PDSB) (“P...
Více zde

close

Dokumenty nejsou k dispozici

preloader